Abnormal hemoglobin H band in myelodysplastic syndromes (MDS): A case report

被引:2
作者
Liu, Cong [1 ]
Zou, Cuicui [1 ]
Zou, Shuhui [1 ]
Wang, Qun [2 ]
Xiao, Dejun [1 ]
Zhang, Liqin [1 ]
机构
[1] Ganzhou Peoples Hosp, Ganzhou 341000, Jiangxi, Peoples R China
[2] Luneng Biotechnol Shenzhen Co LTD, Shenzhen 518000, Peoples R China
关键词
Myelodysplastic syndrome; Abnormal hemoglobin H band; ACUTE MYELOID-LEUKEMIA; SIDEROBLASTIC ANEMIA; ALPHA-THALASSEMIA; INACTIVATION; CYTOGENETICS; EXPRESSION; SURVIVAL; CHILDREN; GENE;
D O I
10.1016/j.tracli.2020.10.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myelodysplastic syndrome (MDS) is a group of heterogeneous diseases derived from hematopoietic stem cells characterized by hemolytic anemia and high risk of conversion to acute leukemia. MDS is an age-related disease in which approximately 80% of patients are over 60years of age, male and female. Anemia is the most common clinical condition, and many patients are also associated with infection and bleeding. When the amount of alpha globin synthesis is insufficient, the remaining beta chain forms tetramer beta 4, i.e. HbH. The latter forms a precipitate in red blood cells, leading to hemolytic anemia, called HbH disease, the majority of which is congenital, a small number of patients with myelodysplastic syndrome and acute myeloid leukemia may appear HbH (called acquired HbH disease). We reported a 71years old male patient diagnosed as myelodysplastic syndromes (MDS) in our hospital. The patient has a negative alpha-thalassemia gene test. The H band is detected by hemoglobin electrophoresis. This article analyzed and discussed this case with MDS, as well reviewed MDS. (C) 2020 Published by Elsevier Masson SAS on behalf of Societe francaise de transfusion sanguine(SFTS).
引用
收藏
页码:206 / 210
页数:5
相关论文
共 50 条
  • [31] The AML-MDS interface-leukemic transformation in myelodysplastic syndromes
    Porwit A.
    Saft L.
    Journal of Hematopathology, 2011, 4 (2) : 69 - 79
  • [32] Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study
    Kathleen M. Wesa
    Susanna Cunningham-Rundles
    Virginia M. Klimek
    Emily Vertosick
    Marci I. Coleton
    K. Simon Yeung
    Hong Lin
    Stephen Nimer
    Barrie R. Cassileth
    Cancer Immunology, Immunotherapy, 2015, 64 : 237 - 247
  • [33] Targeting hypomethylation of DNA to achieve cellular differentiation in myelodysplastic syndromes (MDS)
    Silverman, LR
    ONCOLOGIST, 2001, 6 : 8 - 14
  • [34] The Role of Hepcidin in Myelodysplastic Syndromes (MDS): A Systematic Review of Observational Studies
    Slomka, Artur
    Pokrzywa, Anna
    Strzala, Dominika
    Kubiaczyk, Maja
    Wesolowska, Oliwia
    Denkiewicz, Kinga
    Styczynski, Jan
    CANCERS, 2024, 16 (02)
  • [35] Neutrophilic panniculitis with myelodysplastic syndromes presenting as pustulosis: Case report and review of the literature
    Chen, HC
    Kao, WY
    Chang, DM
    Gao, HW
    Lai, WY
    Lai, JH
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 76 (01) : 61 - 65
  • [36] ABNORMAL REGIONAL HYPERMETHYLATION OF THE CALCITONIN-GENE IN MYELODYSPLASTIC SYNDROMES
    DHODAPKAR, M
    GRILL, J
    LUST, JA
    LEUKEMIA RESEARCH, 1995, 19 (10) : 719 - 726
  • [37] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
    Bacher, Ulrike
    Schnittger, Susanne
    Kern, Wolfgang
    Weiss, Tamara
    Haferlach, Torsten
    Haferlach, Claudia
    ANNALS OF HEMATOLOGY, 2009, 88 (12) : 1207 - 1213
  • [38] Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): When, how and for whom?
    Marcondes, Mario
    Deeg, H. Joachim
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (01) : 67 - 77
  • [39] Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: Report from the Dutch Working Party on Flow Cytometry in MDS
    Westers, Theresia M.
    van der Velden, Vincent H. J.
    Alhan, Canan
    Bekkema, Roelof
    Bijkerk, Andre
    Brooimans, Rik A.
    Cali, Claudia
    Drager, Angelika M.
    de Haas, Valerie
    Homburg, Christa
    de Jong, Anja
    Kuiper-Kramer, P. A.
    Leenders, Marije
    Lommerse, Ingrid
    Marvelde, Jeroen G. te
    van der Molen-Sinke, Joke K.
    Moshaver, Bijan
    Mulder, Andre B.
    Preijers, Frank W. M. B.
    Schindhelm, Roger K.
    van der Sluijs, Alita
    van Wering, Elisabeth R.
    Westra, August H.
    van de Loosdrecht, Arjan A.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 422 - 430
  • [40] Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS)
    Yarosh, Rina
    Roesler, Michelle A.
    Murray, Thomas
    Cioc, Adina
    Hirsch, Betsy
    Nguyen, Phuong
    Warlick, Erica
    Poynter, Jenny N.
    CANCER CAUSES & CONTROL, 2021, 32 (03) : 241 - 250